Extended Data Table 1 Main clinical diagnosis and patient characteristics of the EMB cohort

From: Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis

 

Acute myocarditisa (n = 5)

Inflammatory cardiomyopathya (n = 8)

Heart transplantationb (n = 7)

Dilated cardiomyopathya (n = 3)

Total (n = 23)

Sex

     

 Female (%)

2 (40.0%)

1 (12.5%)

2 (28.6%)

1 (33.3%)

6 (26.1%)

 Male (%)

3 (60.0%)

7 (87.5%)

5 (71.4%)

2 (66.7%)

17 (73.9%)

Age (years)

     

 Mean (s.d.)

42.0 (18.07)

54.8 (14.67)

55.0 (9.66)

56.0 (5.20)

52.2 (13.6)

 Median (minimum, maximum)

34.0 (27.0, 70.0)

56.5 (32.0, 76.0)

57.0 (34.0, 62.0)

59.0 (59.0, 50.0)

57.0 (27.0, 76.0)

Recruiting center c

     

 Zurich (%)

3 (60.0%)

3 (37.5%)

5 (71.4%)

0 (0.0%)

11 (47.8%)

 Graz (%)

2 (40.0%)

5 (62.5%)

2 (28.6%)

3 (100.0%)

12 (52.2%)

  1. a Main clinical diagnosis as documented in the patient information system.
  2. b EMBs were obtained as part of the routine clinical follow-up of heart transplant patients.
  3. c Recruiting centers: Clinic for Cardiology, University Hospital Zurich, Zurich, Switzerland; Division of Cardiology, University Hospital Graz, Graz, Austria.
  4. Main clinical diagnosis and characteristics from patients with acute myocarditis (n = 5), inflammatory cardiomyopathy (n = 8), dilated cardiomyopathy (n = 3) or undergoing heart transplantation (n = 7) who underwent EMB.
Back to article page